-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Pear Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2021 to Q4 2022.
- Pear Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2022 was 139M shares, a 22.4% increase year-over-year.
- Pear Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 139M shares, a 22.4% increase from 2021.
- Pear Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 113M shares, a 27% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)